These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 24078938)

  • 1. Challenges in the diagnosis and management of autoimmune hepatitis.
    Czaja AJ
    Can J Gastroenterol; 2013 Sep; 27(9):531-9. PubMed ID: 24078938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and Management of Autoimmune Hepatitis: Current Status and Future Directions.
    Czaja AJ
    Gut Liver; 2016 Mar; 10(2):177-203. PubMed ID: 26934884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes.
    Baven-Pronk AM; Coenraad MJ; van Buuren HR; de Man RA; van Erpecum KJ; Lamers MM; Drenth JP; van den Berg AP; Beuers UH; den Ouden J; Koek GH; van Nieuwkerk CM; Bouma G; Brouwer JT; van Hoek B
    Aliment Pharmacol Ther; 2011 Aug; 34(3):335-43. PubMed ID: 21668459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and prospective pharmacotherapy for autoimmune hepatitis.
    Czaja AJ
    Expert Opin Pharmacother; 2014 Aug; 15(12):1715-36. PubMed ID: 24961409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonstandard drugs and feasible new interventions for autoimmune hepatitis: part I.
    Czaja AJ
    Inflamm Allergy Drug Targets; 2012 Oct; 11(5):337-50. PubMed ID: 22563779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress in the diagnosis and treatment of autoimmune hepatitis.
    Czaja AJ
    Minerva Med; 2008 Dec; 99(6):549-68. PubMed ID: 19034254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory to standard therapy.
    Devlin SM; Swain MG; Urbanski SJ; Burak KW
    Can J Gastroenterol; 2004 May; 18(5):321-6. PubMed ID: 15152283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and management of autoimmune hepatitis.
    Czaja AJ
    Clin Liver Dis; 2015 Feb; 19(1):57-79. PubMed ID: 25454297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histological changes after the use of mycophenolate mofetil in autoimmune hepatitis.
    Brunt EM; Di Bisceglie AM
    Hum Pathol; 2004 Apr; 35(4):509-12. PubMed ID: 15116334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Empiric therapy of autoimmune hepatitis with mycophenolate mofetil: comparison with conventional treatment for refractory disease.
    Czaja AJ; Carpenter HA
    J Clin Gastroenterol; 2005 Oct; 39(9):819-25. PubMed ID: 16145346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the diagnosis and management of autoimmune hepatitis.
    Dalekos GN; Samakidou A; Lyberopoulou A; Banakou E; Gatselis NK
    Pol Arch Intern Med; 2022 Sep; 132(9):. PubMed ID: 36093593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of immunosuppression in autoimmune hepatitis: A current literature review.
    Cropley A; Weltman M
    Clin Mol Hepatol; 2017 Mar; 23(1):22-26. PubMed ID: 28288505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-classical phenotypes of autoimmune hepatitis and advances in diagnosis and treatment.
    Czaja AJ; Bayraktar Y
    World J Gastroenterol; 2009 May; 15(19):2314-28. PubMed ID: 19452572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine.
    Richardson PD; James PD; Ryder SD
    J Hepatol; 2000 Sep; 33(3):371-5. PubMed ID: 11019991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycophenolate mofetil as a rescue therapy for autoimmune hepatitis patients who are not responsive to standard therapy.
    Fallatah HI; Akbar HO
    Expert Rev Gastroenterol Hepatol; 2011 Aug; 5(4):517-22. PubMed ID: 21780898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug choices in autoimmune hepatitis: part B--Nonsteroids.
    Czaja AJ
    Expert Rev Gastroenterol Hepatol; 2012 Sep; 6(5):617-35. PubMed ID: 23061712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolate mofetil treatment in patients with autoimmune hepatitis failing standard therapy with prednisolone and azathioprine.
    Giannakopoulos G; Verbaan H; Friis-Liby IL; Sangfelt P; Nyhlin N; Almer S;
    Dig Liver Dis; 2019 Feb; 51(2):253-257. PubMed ID: 30389427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of severe refractory lupus hepatitis with mycophenolate mofetil.
    Tagawa Y; Saito T; Takada K; Kawahata K; Kohsaka H
    Lupus; 2016 Apr; 25(5):543-6. PubMed ID: 26762472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus.
    Chatur N; Ramji A; Bain VG; Ma MM; Marotta PJ; Ghent CN; Lilly LB; Heathcote EJ; Deschenes M; Lee SS; Steinbrecher UP; Yoshida EM
    Liver Int; 2005 Aug; 25(4):723-7. PubMed ID: 15998421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the current treatment of autoimmune hepatitis.
    Czaja AJ
    Dig Dis Sci; 2012 Aug; 57(8):1996-2010. PubMed ID: 22476586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.